Skip to main content
. Author manuscript; available in PMC: 2022 Apr 2.
Published in final edited form as: J Clin Virol. 2018 Apr 10;104:1–4. doi: 10.1016/j.jcv.2018.04.006

Table 2.

Patient demographics and clinical symptoms.

Reference GI/GII method Gender Age Median (range)years Diarrhea only (%)a Vomiting only (%)a Diarrhea and vomiting (%)a Fever (%)b
Children Norovirus GI/GII positiv M: 41 3 2 31 44 20
 (N=266) (n = 79; 29.7%) F: 38 (0.17–16.1) (2.5) (39.2) (55.7) (25.3)
Norovirus Negative M: 110 2 26 71 87 96
(n = 187; 70.3%) F: 77 (0.04–18) (13.9) (38.0) (46.5) (51.3)
Adults Norovirus GI/GII positive M: 66 75 47 4 97 24
 (N = 453) (n = 180; 39.7%) F: 114 (19–101) (26.1) (2.2) (53.9) (13.3)
Norovirus Negative M: 230 65 219 3 45 11
(n = 273; 60.3%) F: 43 (21–99) (80.2) (1.1) (16.5) (4.03)
Overall Norovirus GI/GII positive M: 107 52 49 35 141 44
 (N = 719) (n = 259; 36.0%) F: 152 (0.17–101) (18.9) (13.5) (54.4) (16.9)
Norovirus Negative M: 340 51 245 74 132 107
(n = 460; 64.0%) F: 120 (0.04–99) (53.3) (16.1) (28.7) (23.3)
a

Data missing for 34 subjects.

b

Fever temperature defined as 37.2 °C or more. Data missing for 34 subjects.